HOUSTON, Nov. 13 /PRNewswire/ -- Life threatening to cats and alarming to pet owners, the incidence of feline diabetes is on the rise. Conservative estimates show there are 250,000 diabetic cats in the U.S. at any one time, and one feline diabetes expert believes there could be as many as 1.5 million.
(Photo: http://www.newscom.com/cgi-bin/prnh/20071113/NYFNSZ05)
To better manage feline diabetes, BCP Veterinary Pharmacy offers BCP PZI(R) Bovine Insulin, a bovine-derived protamine zinc insulin, which is the closest match to feline insulin available.
"With only one amino acid difference, cats can accept BCP PZI(R) Bovine Insulin better because it is much more like their own," said Jennifer Gimon, registered pharmacist and founder of BCP Veterinary Pharmacy. "Recombinant human insulin is the furthest removed from feline insulin with four amino acid differences. Porcine-derived insulin has three amino acid differences and is structurally closest to canine insulin."
Using bovine PZI has been integral to success with Tight Regulation Protocol, the strategy for curing feline diabetes pioneered by Elizabeth Hodgkins, DVM, Esq.
"I have not found any insulin equal to or superior to bovine-source PZI insulin for managing those cats that require insulin for any period of time," Hodgkins explains in her book, "Your Cat: Simple New Secrets to a Longer, Stronger Life" (Thomas Dunne Books, 2007). She says it can be dosed at six to twelve hour intervals, allows good control of the diabetic cat and is "far superior to that from NPH, Humulin insulin, or the newer human products called 'Lantus' (glargine) or 'Levemir.'"
Compounded with insulin crystals that meet all USP Monograph Specifications, BCP PZI(R) Bovine Insulin is subject to ongoing analysis to ensure high quality control.
For more information, visit the website at
| SOURCE BCP Veterinary Pharmacy Copyright©2007 PR Newswire. All rights reserved |